Mitch Sanders, PhD

Mitch Sanders is a Serial Entrepreneur, C-Level Executive, and Scientist developing advanced wound care products for the past 30 years with 25 peer reviewed publications and 45 world-wide patents (Google Scholar citations, https://biturl.top/YRruYn). Over the past 20 years Dr. Sanders has secured over $65M in strategic partnerships for new product development for his lab. Dr. Sanders was founder and CEO of ECI Biotech (1998-2016) and his company developed the first infection diagnostic for chronic wounds (Bacterial Status), sold by WoundChek Labs. Mitch later worked at Alira Health as CSO, Board Member, and Founder/CEO of two additional startups (WoundForce Inc., and Firefly Innovations, LLC) that he sold to Alira Health. In 2023, Dr. Sanders used a portion of his equity to buy his lab out of the CRO and is currently the owner and Chief Executive Officer of ProDevLabs LLC, a Premier Wound Care R&D and Preclinical CRO in Southborough MA.